AI designs new drugs based on protein structures

A new computer process developed by chemists at ETH Zurich makes it possible to generate active pharmaceutical ingredients quickly and easily based on a protein’s three-dimensional surface. The new process could revolutionise drug research.

Molecule developed with AI
A new generative AI develops molecules from scratch in such a way that they precisely match the protein they are to interact with. (Visualisations: ETH Zurich / Gisbert Schneider)

Comments

Leave a comment

Leave a comment

We are happy if you comment on articles on ETH channels, ask questions or respond to comments from other readers. Please note our comment policy when doing so.

No comments yet